Other MR analyses also provide partial support, with the weighted median suggesting that elevated TNFRSF9 levels increased the risk of NAFLD (or = 1.42, 1.07–1.89, p = 0.015), while elevated levels of LIF were negatively correlated with the risk of NAFLD (or = 0.63, 0.44–0.92, p = 0.016). The gene discussed is LIF; the disease is metabolic dysfunction-associated steatotic liver disease.